Cardinal Health Stock News

Liberty One Investment Management LLC increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 311,384 shares of the companys stock after purchasing an additional 8,931 shares during the period. Cardinal Health makes up 2.6% []

This article was originally published on TipRanks.com Dublin-headquartered Cardinal Health (CAH) is a distributor of healthcare supplies, including drugs and laboratory products. The post What Do Cardinal Healths Risk Factors Reveal? appeared first on Smarter Analyst .

Cardinal Health, Inc. (NYSE:CAH) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 5,630,000 shares, a decline of 31.6% from the October 31st total of 8,230,000 shares. Based on an average trading volume of 3,340,000 shares, the days-to-cover ratio is []

Pflug Koory LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 11,390 shares of the companys stock after selling 375 shares during the quarter. Pflug Koory LLCs holdings in Cardinal Health were worth $563,000 at the end of the most recent reporting period. Other []

Cardinal Health, Inc. (NYSE:CAH) has been assigned an average rating of “Hold” from the twelve brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month […]

SYDNEY, Dec. 2, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, and Cardinal Health (NYSE: CAH), are pleased to announce that the companies have

Vivid Financial Management Inc. cut its position in Cardinal Health, Inc. (NYSE:CAH) by 25.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,641 shares of the companys stock after selling 2,258 shares during the quarter. Vivid Financial Management Inc.s holdings in Cardinal Health were []

The Global Axillary Crutches Market Is Witnessing High Growth Owing To the Increasing Cases of Disabilities in the World Axillary Crutches Market, by Material Type (Aluminum, Stainless Steel, Wooden, and Others) by Age Group (Adult and Pediatrics), by Region (North

The global Prosthetic Graft market size is projected to reach a CAGR of 6.2% during 2021-2027. A prosthetic graft is a tubular structure of polyester material that is being used to fix or replace a blood. It has no hazardous

Cardinal Health (NYSE: CAH) has recently received a number of price target changes and ratings updates: 11/15/2021 Cardinal Health had its price target lowered by analysts at Credit Suisse Group AG from $53.00 to $50.00. They now have a neutral rating on the stock. 11/15/2021 Cardinal Health was downgraded by analysts at Zacks [] The post Research Analysts Recent Ratings Updates for Cardinal Health (CAH) appeared first on ETF Daily News .

Cardinal Health, Inc. (CAH) shares closed today at 1.0% above its 52 week low of $47.14, giving the company a market cap of $13B. The stock is currently down 8.8% year-to-date, down 8.3% over the past 12 months, and down 20.4% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 28.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -158.0% The company's stock price performance over the past 12 months lags the peer average by -147.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -9.3% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

As people kick off Black Friday shopping across the U.S., five dividend aristocrat stocks with high guru ownership that are trading near 52-week lows are Cardinal Health Inc. ( CAH , Financial), AT&T

Overview of Global Electro-Medical Equipment Market: The primary sources employed while crafting Electro-Medical Equipment Market report include the industry experts from the Healthcare industry comprising the management corporation, processing organizations, analytical service suppliers of the industrys value chain. It reveals the

Cardinal Health (NYSE:CAH) updated its FY 2022 earnings guidance on Tuesday. The company provided earnings per share guidance of $5.600-$5.900 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.760. The company issued revenue guidance of -. Shares of CAH traded down $0.36 during trading hours on Thursday, reaching $48.78. []

Overview: Home healthcare includes services and devices for patients that regularly monitor vital signs such as body temperature, blood pressure pulse rate and chronic health conditions. Rising cases of chronic diseases is expected to boost growth of the global home healthcare